Minimally invasive cytologic evaluation leading to the diagnosis of TFE3‐rearranged renal cell carcinoma: A case report
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.25042
Abstract: TFE3‐rearranged renal cell carcinoma (RCC) has been categorized as a molecularly defined renal carcinoma in the 2022 WHO classification of tumors as it does not demonstrate a specific genotype–phenotype correlation. However, in order to arrive… read more here.
Keywords: cell carcinoma; renal cell; diagnosis; rearranged renal ... See more keywords
A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Genes"
DOI: 10.1002/gcc.23127
Abstract: Renal cell carcinoma (RCC) with rearrangement of transcription factor for immunoglobulin heavy‐chain enhancer 3 (TFE3; TFE3‐rearranged RCC) at Xp11.2 is a rare tumor entity but the most frequent among the microphthalmia transcription factor family translocation… read more here.
Keywords: cell carcinoma; translocation; vcp tfe3; tfe3 rearranged ... See more keywords
TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases.
Sign Up to like & getrecommendations! Published in 2020 at "Annals of diagnostic pathology"
DOI: 10.1016/j.anndiagpath.2020.151487
Abstract: Epithelioid hemangioendothelioma (EHE) is a rare malignant angiocentric vascular neoplasm. Around 90% of classic EHE has a t(1;3)(p36;q25) that results in a WWTR1-CAMTA1 fusion gene, a histologically distinctive subset of EHE has been recently shown… read more here.
Keywords: tfe3 rearranged; epithelioid hemangioendothelioma; cases tfe3; two cases ... See more keywords